Literature DB >> 31201506

Spread through air spaces (STAS) is a predictor of poor outcome in atypical carcinoids of the lung.

Serdar Altinay1, Jasna Metovic2, Federica Massa2, Gaia Gatti2, Paola Cassoni3, Giorgio Vittorio Scagliotti2, Marco Volante4, Mauro Papotti2.   

Abstract

Spread through air spaces (STAS) have been recently recognized as a prognostic factor for adenocarcinoma and squamous cell carcinoma of the lung. Pulmonary neuroendocrine neoplasms (NENs) include tumors with different morphology and a heterogeneous clinical behavior. Among atypical carcinoids (ACs), new prognostic factors able to refine prognosis are needed. In the present study, a retrospective series of 91 surgically resected ACs was investigated, in parallel with 191 control cases of typical carcinoids (TCs) and of high-grade small- and large-cell neuroendocrine carcinomas, to assess the presence and potential prognostic role of STAS. STAS was defined by the presence of neoplastic nests or single cells in air spaces beyond the tumor edge. Clinicopathological parameters and survival were correlated by univariate and multivariate analyses. STAS was identified in 48% of ACs (44/91) compared to 20.5% of TCs and 71-88% of high-grade large- and small-cell carcinomas in the control group. In the carcinoid group, presence of STAS was significantly correlated with unfavorable parameters, such as high tumor stage, positive nodal status, high Ki-67 index, presence of angioinvasion, and with adverse disease outcome, shorter overall survival, and time to progression. In conclusion, the presence of STAS is an additional relevant adverse prognostic factor in pulmonary AC that currently has the most unpredictable outcome and the most controversial treatment strategy.

Entities:  

Keywords:  Atypical carcinoid; Lung; Neuroendocrine neoplasm; Prognosis; Spread through air spaces (STAS)

Mesh:

Year:  2019        PMID: 31201506     DOI: 10.1007/s00428-019-02596-8

Source DB:  PubMed          Journal:  Virchows Arch        ISSN: 0945-6317            Impact factor:   4.064


  19 in total

Review 1.  Pulmonary neuroendocrine (carcinoid) tumors: European Neuroendocrine Tumor Society expert consensus and recommendations for best practice for typical and atypical pulmonary carcinoids.

Authors:  M E Caplin; E Baudin; P Ferolla; P Filosso; M Garcia-Yuste; E Lim; K Oberg; G Pelosi; A Perren; R E Rossi; W D Travis
Journal:  Ann Oncol       Date:  2015-02-02       Impact factor: 32.976

2.  The 2015 World Health Organization Classification of Lung Tumors: Impact of Genetic, Clinical and Radiologic Advances Since the 2004 Classification.

Authors:  William D Travis; Elisabeth Brambilla; Andrew G Nicholson; Yasushi Yatabe; John H M Austin; Mary Beth Beasley; Lucian R Chirieac; Sanja Dacic; Edwina Duhig; Douglas B Flieder; Kim Geisinger; Fred R Hirsch; Yuichi Ishikawa; Keith M Kerr; Masayuki Noguchi; Giuseppe Pelosi; Charles A Powell; Ming Sound Tsao; Ignacio Wistuba
Journal:  J Thorac Oncol       Date:  2015-09       Impact factor: 15.609

3.  Tumor Spread through Air Spaces is an Important Pattern of Invasion and Impacts the Frequency and Location of Recurrences after Limited Resection for Small Stage I Lung Adenocarcinomas.

Authors:  Kyuichi Kadota; Jun-Ichi Nitadori; Camelia S Sima; Hideki Ujiie; Nabil P Rizk; David R Jones; Prasad S Adusumilli; William D Travis
Journal:  J Thorac Oncol       Date:  2015-05       Impact factor: 15.609

Review 4.  Pulmonary carcinoid: presentation, diagnosis, and outcome in 142 cases in Israel and review of 640 cases from the literature.

Authors:  G Fink; T Krelbaum; A Yellin; D Bendayan; M Saute; M Glazer; M R Kramer
Journal:  Chest       Date:  2001-06       Impact factor: 9.410

Review 5.  The assessment of Ki-67 as a prognostic marker in neuroendocrine tumours: a systematic review and meta-analysis.

Authors:  Sebastian Richards-Taylor; Sean M Ewings; Eleanor Jaynes; Charles Tilley; Sarah G Ellis; Thomas Armstrong; Neil Pearce; Judith Cave
Journal:  J Clin Pathol       Date:  2015-12-17       Impact factor: 3.411

6.  Histologic features of low- and intermediate-grade neuroendocrine carcinoma (typical and atypical carcinoid tumors) of the lung.

Authors:  Koji Tsuta; Maria G Raso; Neda Kalhor; Diane D Liu; Ignacio I Wistuba; Cesar A Moran
Journal:  Lung Cancer       Date:  2010-05-11       Impact factor: 5.705

7.  Pulmonary neuroendocrine tumors: incidence and prognosis of histological subtypes. A population-based study in Denmark.

Authors:  Halla Skuladottir; Fred R Hirsch; Heine H Hansen; Jørgen H Olsen
Journal:  Lung Cancer       Date:  2002-08       Impact factor: 5.705

Review 8.  Ki-67 antigen in lung neuroendocrine tumors: unraveling a role in clinical practice.

Authors:  Giuseppe Pelosi; Guido Rindi; William D Travis; Mauro Papotti
Journal:  J Thorac Oncol       Date:  2014-03       Impact factor: 15.609

9.  Grading the neuroendocrine tumors of the lung: an evidence-based proposal.

Authors:  G Rindi; C Klersy; F Inzani; G Fellegara; L Ampollini; A Ardizzoni; N Campanini; P Carbognani; T M De Pas; D Galetta; P L Granone; L Righi; M Rusca; L Spaggiari; M Tiseo; G Viale; M Volante; M Papotti; G Pelosi
Journal:  Endocr Relat Cancer       Date:  2013-12-16       Impact factor: 5.678

10.  Comprehensive pathological analyses in lung squamous cell carcinoma: single cell invasion, nuclear diameter, and tumor budding are independent prognostic factors for worse outcomes.

Authors:  Kyuichi Kadota; Jun-Ichi Nitadori; Kaitlin M Woo; Camelia S Sima; David J Finley; Valerie W Rusch; Prasad S Adusumilli; William D Travis
Journal:  J Thorac Oncol       Date:  2014-08       Impact factor: 15.609

View more
  5 in total

1.  Lung neuroendocrine tumors: a new addition to the evolving list of spread through air spaces.

Authors:  Hironori Uruga; Mari Mino-Kenudson
Journal:  Transl Lung Cancer Res       Date:  2019-12

Review 2.  Spread Through Air Spaces (STAS) in Lung Cancer: A Multiple-Perspective and Update Review.

Authors:  Meng Jia; Shili Yu; Hongwen Gao; Ping-Li Sun
Journal:  Cancer Manag Res       Date:  2020-04-23       Impact factor: 3.989

Review 3.  Significance of tumor spread through air spaces (STAS) in lung cancer from the pathologist perspective.

Authors:  Mari Mino-Kenudson
Journal:  Transl Lung Cancer Res       Date:  2020-06

Review 4.  [Research Progress on Spread Through Air Spaces of Lung Cancer].

Authors:  Lei Fan; Ping He
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2021-12-23

5.  Poor Prognosis of Grade 2 Spread Through Air Spaces in Neuroendocrine Tumors.

Authors:  Mincheol Chae; Sukki Cho; Jin-Haeng Chung; Sungwon Yum; Kwhanmien Kim; Sanghoon Jheon
Journal:  J Chest Surg       Date:  2022-04-05
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.